J&J Hones In On Research Alliances, Human Capital As It Expands Singapore Hub
J&J is building its broad presence in Asia Pacific with the opening of an expanded regional hub in Singapore that will pursue R&D partnership, "design-led" health solutions, and human resource development.
You may also be interested in...
As it narrows focus to core therapeutic areas ahead of acquiring Shire, Takeda sends uterine fibroid and endometriosis rights to compatriot firm ASKA. Zai Lab and Crescendo team up on antibody candidate for inflammatory indications.
Open Innovation and global partnering are becoming one of the most frequent themes of bio conferences in South Korea and elsewhere. Scrip talked to global experts at the recent Bio Korea 2018 meeting about their views on the current climate and trends for open innovation in Asia, as well as some challenges and benefits in pursuing open innovation approaches with Asian companies.
By the second quarter of 2019, the doors to a new Johnson & Johnson innovation facility will open in Shanghai, China – the ninth unit to launch under the US giant's JLABS initiative but only the first site outside of North America.